Research Article

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway

Figure 8

Rab22a promotes the EMT process of thyroid cancer cells. The western blot analysis results revealed the expression of EMT-related proteins induced by Rab22a overexpression or knockdown in TPC1 (a) and K1 cells (b). Statistical data were the of the three repeated independent trials, , , and .
(a)
(b)